Home > Insider Trading > Filing (0001179110-14-008775)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1065087	Albany Molecular Research Inc	AMRI	Services-Commercial Physical & Biological Research (8731)	141742717

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1449207	R Steven Hagen	26 Corporate Circle Albany NY 12203	Svp Pharmaceutical Dev & Mfg	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-16	1,250	$2.93	34,683	No	4	M	Direct
Common Stock	Disposition	2014-05-16	1,250	$15.45	33,433	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option to Purchase Common Stock	Disposition	2014-05-16	1,250	$2.93	1,250	$2.93

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
18,750		2022-02-17	No	4	M	Direct

Footnotes

50% of grant is time based and 50% is performance based. Time based grant vests 25% per year on each of the first 4 anniversaries of the date of grant (February 17, 2012). Performance based grant vests 25% per year on each of the first 4 anniversaries of the grant date if (1) certain performance criteria related to the Company's operating profitability are reached and (2) the grantee is employed on such anniversary date; if the foregoing criteria are not met on any anniversary date, 25% of the shares of options under the performance award will immediately be forfeited. The 2,500 shares being exercised represent a portion of the vested grants. 50% of the intial grant is not yet exercisable.
The reported price represents the weighted average sales price for such shares. The actual range of sales prices for such shares was $15.45 - $15.47. Upon request of the Commission, the exact number of shares sold at each price will be provided.